tiprankstipranks

GB:3LAZ Similar ETFs

Compare

Comparison Results

Name
Price
Price Change
Price Target
Smart Score
Expense Ratio
Asset Under Management
Follow
Xtrackers MSCI USA Health Care UCITS ETF
$59.06
$79.64
(34.84% Upside)
12.00%
646.85M
iShares MSCI World Health Care Sector ESG UCITS ETF USD
401.98p
555.05p
(38.08% Upside)
25.00%
102.18M
Mul Ly W Heal C Shs -C-USD- Capitalisation
$519.50
$639.92
(23.18% Upside)
30.00%
93.06M
Xtrackers MSCI Global SDG 3 Good Health UCITS ETF
$34.66
$46.81
(35.08% Upside)
35.00%
83.92M
Invesco S&P World Health Care ESG UCITS ETF AccumUSD
$6.00
$8.14
(35.59% Upside)
18.00%
71.26M
Legal & General UCITS ETF PLC - L&G Healthcare Breakthrough UCITS ETF AccumUSD
$12.71
$16.17
(27.20% Upside)
49.00%
67.84M
L&G Pharma Breakthrough UCITS ETF
$10.56
$16.01
(51.62% Upside)
49.00%
19.24M
Kronos Strategy ETP
$5.37
287.00%
311.71K
GraniteShares 3x Long BP Daily ETP
1380.50p
324.00%
1.75M
GraniteShares 3x Short Astrazeneca Daily ETP
1560.00p
264.00%
169.85K

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
GB:XUHC
Xtrackers MSCI USA Health Care UCITS ETF
59.06
0.88
1.51%
GB:WHCA
iShares MSCI World Health Care Sector ESG UCITS ETF USD
401.98
-20.17
-4.78%
GB:HLTW
Mul Ly W Heal C Shs -C-USD- Capitalisation
519.50
4.25
0.82%
GB:XDG3
Xtrackers MSCI Global SDG 3 Good Health UCITS ETF
34.66
1.31
3.93%
GB:WHCE
Invesco S&P World Health Care ESG UCITS ETF AccumUSD
6.00
0.09
1.52%
GB:DOCT
Legal & General UCITS ETF PLC - L&G Healthcare Breakthrough UCITS ETF AccumUSD
12.71
1.16
10.04%
GB:BIOT
L&G Pharma Breakthrough UCITS ETF
10.56
0.78
7.98%
GB:KRON
Kronos Strategy ETP
5.37
0.27
5.29%
GB:3LBP
GraniteShares 3x Long BP Daily ETP
1,380.50
-386.75
-21.88%
GB:3SAZ
GraniteShares 3x Short Astrazeneca Daily ETP
1,560.00
-1,183.00
-43.13%
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis